Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
In Vitro Cell Dev Biol Anim ; 52(8): 799-805, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27251159

ABSTRACT

The main constituent of green tea, (-)-Epigallocatechin-3-O-gallate (EGCG), is known to have cancer-specific chemopreventive effects. In the present work, we investigated how EGCG suppresses cell adhesion by comparing the adhesion of human pancreatic cancer cells (AsPC-1 and BxPC-3) and their counterpart, normal human embryonic pancreas-derived cells (1C3D3), in catechin-containing media using organosilane monolayer templates (OMTs). The purpose of this work is (1) to evaluate the quantitativeness in the measurement of cell adhesion with the OMT and (2) to show how green-tea catechins suppress cell adhesion in a cancer-specific manner. For the first purpose, the adhesion of cancer and normal cells was compared using the OMT. The cell adhesion in different type of catechins such as EGCG, (-)-Epicatechin-3-O-gallate (ECG) and (-)-Epicatechin (EC) was also evaluated. The measurements revealed that the anti-adhesion effect of green-tea catechins is cancer-specific, and the order is EGCG≫ECG>EC. The results agree well with the data reported to date, showing the quantitativeness of the new method. For the second purpose, the contact area of cells on the OMT was measured by reflection interference contrast microscopy. The cell-OMT contact area of cancer cells decreases with increasing EGCG concentration, whereas that of normal cells remains constant. The results reveal a twofold action of EGCG on cancer cell adhesion-suppressing cell attachment to a candidate adhesion site and decreasing the contact area of the cells-and validates the use of OMT as a tool for screening cancer cell adhesion.


Subject(s)
Catechin/analogs & derivatives , Cell Adhesion/drug effects , Pancreas/drug effects , Pancreatic Neoplasms/drug therapy , Catechin/administration & dosage , Catechin/chemistry , Cell Line, Tumor , Humans , Pancreatic Neoplasms/pathology , Tea/chemistry
2.
J Phys Chem B ; 120(7): 1221-7, 2016 Feb 25.
Article in English | MEDLINE | ID: mdl-26845066

ABSTRACT

Adhesion of cancer cells with different metastatic potential and anticancer drug resistance has been quantitatively evaluated by using self-assembled monolayer (SAM)-patterned substrates and reflection interference contrast microscopy (RICM). Cell-adhesive SAM spots with optimized diameter could prevent cell-cell adhesion and thus allowed the systematic evaluation of statistically reliable numbers of contact area between single cancer cells and substrates by RICM. The statistical image analysis revealed that highly metastatic mouse melanoma cells showed larger contact area than lowly metastatic cells. We also found that both cancer cell types exhibited distinct transition from the "strong" to "weak" adhesion states with increase in the concentration of (-)-epigallocatechin gallate (EGCG), which is known to exhibit cancer preventive activity. Mathematical analysis of the adhesion transition revealed that adhesion of the highly metastatic mouse melanoma cells showed more EGCG tolerance than that of lowly metastatic cells. Moreover, time-lapse RICM observation revealed that EGCG weakened cancer cell adhesion in a stepwise manner, probably via focal adhesion complex. These results clearly indicate that contact area can be used as a quantitative measure for the determination of cancer phenotypes and their drug resistance, which will provide physical insights into the mechanism of cancer metastasis and cancer prevention.


Subject(s)
Anticarcinogenic Agents/pharmacology , Catechin/analogs & derivatives , Cell Adhesion/drug effects , Microscopy, Interference/methods , Neoplasms/drug therapy , Neoplasms/pathology , Animals , Catechin/pharmacology , Cell Line, Tumor , Drug Resistance, Neoplasm , Humans , Melanoma, Experimental/drug therapy , Melanoma, Experimental/pathology , Mice , Neoplasm Metastasis/drug therapy , Neoplasm Metastasis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...